Curated news and analysis on clinical trials, drug approvals, and medical research.
Multiple institutional investors expanded their stakes in AstraZeneca during the third quarter of 2025, with the stock trading near its 52-week high and maintaining a "Moderate Buy" rating from analysts.
Millions of single-use GLP-1 pens may be improperly disposed of annually, while the supplement industry responds to nutritional gaps created by reduced food intake among users of drugs like Ozempic and Wegovy.
The FDA has filed Savara's biologics license application for MOLBREEVI to treat autoimmune pulmonary alveolar proteinosis, granting Priority Review with a target action date of August 22, 2026.
An international research team has conducted the first comprehensive genetic study of cancer in domestic cats, identifying genetic changes that closely resemble those in human cancers and opening new perspectives for targeted therapies.
Trinity Biotech plc received two separate non-compliance notices from Nasdaq in February 2026 for failing to meet minimum bid price and market value requirements, with 180-day periods to regain compliance or face potential delisting.
Pharmaceutical and life sciences global capability centres in India are using AI, automation, and advanced analytics to reduce drug development timelines from 10-15 years to 9-13 years, while cutting R&D-to-launch costs from 20-30% to 15-25%.
China's brain-computer interface industry is rapidly commercializing with strong policy support, including an $165 million government fund and provincial medical pricing systems. The market is projected to reach $530 million in 2025 and over 120 billion yuan by 2040.
Zimbabwe rolled out lenacapavir, a twice-yearly HIV prevention injection, on Thursday for high-risk populations including sex workers and adolescent girls. The donor-supported program will initially reach 46,000 people across 24 sites.
Research published in Pediatric Research in February 2026 demonstrates that pediatric patients can successfully participate in cross-border clinical trials when language barriers are addressed through translation services and multilingual communication strategies.
NanoViricides is preparing to advance NV-387 into a Phase II clinical trial for Monkeypox in the Democratic Republic of Congo, with regulatory approval received and full funding secured through recent financings totaling approximately $6.2 million.
AbbVie announced a quarterly cash dividend of $1.73 per share, payable May 15, 2026. The company has increased its dividend by over 330 percent since 2013 and remains an S&P Dividend Aristocrat.
A recent usability study examined Epic's Genomic-Indicators, a clinical decision support tool designed to integrate pharmacogenomic data into electronic health records for personalized patient care.
The Pathways clinical trial into puberty blockers has been paused after the MHRA raised concerns about minimum age limits and unquantified long-term biological risks, with recruitment now suspended pending resolution.
Bristol Myers Squibb faces a steep patent cliff with key drugs losing protection between 2027-2029, but newer products like Cobenfy show promise. The stock trades at less than 10 times earnings with a 4.2% dividend yield.
Patients with p53 aberrant or 17p deleted chronic lymphocytic leukemia face a more aggressive disease course requiring specialized treatment approaches including clinical trial enrollment and referral to high-volume centers.
The Kentucky Office of Homeland Security has issued a warning after detecting Cychlorphine, a synthetic drug ten times stronger than fentanyl, in central Kentucky. The drug is contributing to overdose deaths in neighboring regions including East Tennessee.
A measles exposure occurred on February 18 at Nemours Children's Hospital emergency department in Delaware. State health officials are conducting contact tracing and urging unvaccinated exposed individuals to receive MMR vaccine within 72 hours.
The FDA approved acalabrutinib plus venetoclax as the first all-oral, fixed-duration BTK inhibitor regimen for CLL/SLL and cleared monthly dosing for amivantamab in EGFR-mutated NSCLC. Additional regulatory reviews are underway for PCNSL and breast cancer treatments.
Eighty-six countries including the US and China signed a declaration calling for secure and trustworthy AI at the five-day AI Impact Summit in New Delhi, though the statement included no concrete regulatory commitments and drew criticism for being too generic.
Long-term data from the QUASAR extension study show TREMFYA® maintained clinical remission in over 80% of ulcerative colitis patients at Week 140, with more than half achieving endoscopic remission and no new safety concerns observed.
